Contents

Current Drug Therapy, Volume 2 - Number 2

Editorial [Disparity in Pharmacotherapies]

, 2(2): 95

Joachin F. Wernicke


DOI: 10.2174/157488507780619077




Autism Spectrum Disorders: Etiology and Pharmacotherapy

, 2(2): 97 - 103

Mohammad-Reza Mohammadi and Shahin Akhondzadeh


DOI: 10.2174/157488507780619095




A Review of the Current Role of Proton Therapy in Modern Oncology

, 2(2): 105 - 109

Maurizio Amichetti, Augusto Lombardi, Carlo Algranati, Marco Schwarz, Marco Cianchetti and Lamberto Widesott


DOI: 10.2174/157488507780619068




HIV Management: New Approaches

, 2(2): 111 - 119

Supriya S. Shidhaye, Pagar Hemant, Haddadi Majid and Vilasrao Kadam


DOI: 10.2174/157488507780619031




Beta-Blocking Agents and Electroconvulsive Therapy

, 2(2): 121 - 126

Walter W. van den Broek, Theo H.N. Groenland, Paul G.H. Mulder, Ari Kusuma, Tom K. Birkenhager, Esther Pluijms and Jan A. Bruijn


DOI: 10.2174/157488507780619022




Ibopamine Stimulates α-Adrenergic Receptors and D1 Dopaminergic Receptors in the Eye

, 2(2): 127 - 132

Italo Giuffre


DOI: 10.2174/157488507780619112




Transdermal Penetration Enhancers

, 2(2): 133 - 142

Shaji Jessy, Marathe Shripad and Shah Mansi


DOI: 10.2174/157488507780619040




Will Medicinal Cannabinoids Prove to be Useful Clinically?

, 2(2): 143 - 150

Paul F. Smith


DOI: 10.2174/157488507780619059




Emerging Therapies for Type 2 Diabetes

, 2(2): 151 - 160

Anthony H. Stonehouse and David G. Maggs


DOI: 10.2174/157488507780619103




Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine

, 2(2): 161 - 167

Joachim F. Wernicke, Smriti Iyengar and M. Dolores Ferrer-Garcia


DOI: 10.2174/157488507780619086




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science